跳至主要内容
临床试验/ACTRN12608000389303
ACTRN12608000389303招募中3 期

Efficacy of blood glucose self-monitoring and intensive education in patients with type 2 diabetes not receiving insulin: a pilot study

Consorzio Mario Negri Sud0 个研究点目标入组 80 人开始时间: 2008年8月4日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
All

入选标准

  • Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic;
  • Patients on treatment with oral hypoglycaemic agents (OHA) monotherapy (i.e. metformin alone or sulphonyloureas alone or thiazolidinediones (TZDs) alone);
  • No need for insulin treatment;
  • Male and female patients, aged between 45-75 years;
  • Hba1c values between 7% and 9% included (considering a value of 6.0% as the upper limit of normal value)
  • No experience of self monitoring of blood glucose (SMBG) in the previous 12 months (SMBG performed with a frequency of < 1 times/week)
  • Ability and willingness to comply with all study requirements
  • Signature of consent form

排除标准

  • insulin therapy or more than one oral hypoglycaemic agents (OHA);
  • need of self monitoring of blood glucose (SMBG);
  • concomitant serious illnesses causing a reduction of life expectancy;
  • physical or mental problems preventing the self monitoring of blood glucose (SMBG);
  • patient management shared with general practitioner (GP).

研究者

发起方
Consorzio Mario Negri Sud

相似试验

Efficacy of blood glucose self-monitoring and... | 临床试验